Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

RusAgro may start supplying pork to China

11/13/23 RAGR

Bank Saint-Petersburg reported for 9 months of 2023 by RAS

11/13/23 BSPB

RusAgro prepares for redomiciliation

11/13/23 RAGR

Board of Directors of TCS Group is headed by Alexey Malinovsky

11/13/23 T

Levenguc reported for 9 months of 2023 by RAS

11/13/23 LVHK

Tyson Foods announced a quarterly dividend

11/13/23 TSN

Tyson Foods reported for fiscal year 2023

11/13/23 TSN

Sollers starts selling ST6 pickup trucks with diesel engine

11/13/23 SVAV

Bank Kuznetsky reported for 9 months of 2023 by RAS

11/13/23 KUZB

Slavneft-Yaroslavnefteorgsintez reported for 9 months of 2023 by RAS

11/13/23 JNOS